Clinical trial
R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis
NCT00140218 · Bennett, James P., Jr., M.D., Ph.D., Other · Completed
Key facts
| NCT number | NCT00140218 |
|---|---|
| Title | R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis |
| Official title | Futility Study of R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis |
| Lead sponsor | Bennett, James P., Jr., M.D., Ph.D., Other |
| Collaborators | University of Pittsburgh |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis |
| Intervention type | Drug |
| Interventions | R(+) pramipexole dihydrochloride monohydrate |
| Enrollment | 30 |
| Start date | Aug 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Dec 1, 2006 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 8, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: